Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases

PHASE3CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

June 1, 2013

Study Completion Date

March 31, 2022

Conditions
Childhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous LeukemiaChildhood Myelodysplastic SyndromesChronic Phase Chronic Myelogenous Leukemiade Novo Myelodysplastic SyndromesJuvenile Myelomonocytic LeukemiaPreviously Treated Myelodysplastic SyndromesRecurrent Childhood Acute Lymphoblastic LeukemiaSecondary Myelodysplastic Syndromes
Interventions
PROCEDURE

allogeneic bone marrow transplantation

Patients undergo allogeneic BMT

OTHER

laboratory biomarker analysis

Correlative studies

BIOLOGICAL

filgrastim

Given IV

Trial Locations (21)

10595

New York Medical College, Valhalla

14263

Roswell Park Cancer Institute, Buffalo

19104

Children's Hospital of Philadelphia, Philadelphia

27599

University of North Carolina, Chapel Hill

37232

Vanderbilt-Ingram Cancer Center, Nashville

40202

Kosair Children's Hospital, Louisville

43205

Nationwide Children's Hospital, Columbus

46202

Indiana University Medical Center, Indianapolis

Riley Hospital for Children, Indianapolis

48109

C S Mott Children's Hospital, Ann Arbor

60614

Childrens Memorial Hospital, Chicago

63110

Washington University School of Medicine, St Louis

64108

The Childrens Mercy Hospital, Kansas City

68198

University of Nebraska Medical Center, Omaha

75390

University of Texas Southwestern Medical Center, Dallas

80045

Children's Hospital Colorado, Aurora

84113

Primary Children's Medical Center, Salt Lake City

94143

University of California San Francisco Medical Center-Parnassus, San Francisco

91006-3776

Children's Oncology Group, Arcadia

21287-8936

Johns Hopkins University, Baltimore

07601

Hackensack University Medical Center, Hackensack

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00450450 - Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases | Biotech Hunter | Biotech Hunter